|
|
 | | | |
- close
- close
- close
- close
This excerpt taken from the WBMD 10-Q filed Aug 9, 2006. (b) Use
of Proceeds
On September 28, 2005, we sold 7,935,000 shares of our
Class A Common Stock at a price of $17.50 per share in
our initial public offering or IPO. The shares of Class A
Common Stock sold in the IPO were registered under the
Securities Act of 1933, as amended, on a Registration Statement
on
Form S-1
(No. 333-124832).
Our net proceeds from the offering were $125,392 after deducting
underwriting discounts and commissions and our offering
expenses. Through June 30, 2006, the proceeds from the IPO
and the $40,000 cash capital contribution from Emdeon in
September 2005 have been invested in U.S. Treasury Notes
and auction rate securities, and used to fund the Conceptis,
eMedicine and Summex acquisitions, the combined earn out
payments to RxList and MedicineNet of $9,637, capital
expenditures and working capital requirements.
|
| |||||||
